ArticleRadiology2020
Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
Article in Radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05283512 (Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease), which is not on this map. Cited by 210 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial
Who cites it
210 citing papers in PubMed, 4 syntheses or guidelines pooled it, 551 citations in OpenAlex.
- Cross-sectional imaging for presurgical planning of dialysis circuit vascular access creation in the end stage renal disease patient population.The international journal of cardiovascular imaging · 2026Pooled it
- Remote ischemic preconditioning reduces contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials.Frontiers in cardiovascular medicine · 2026Pooled it
- Diagnostic Accuracy of Non-Contrast CT for Acute Appendicitis in the Emergency Department: A Systematic Review and Meta-Analysis.Medicina (Kaunas, Lithuania) · 2025Pooled it
- Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2021Pooled it
- Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial.European journal of clinical pharmacology · 2026Trial
- Lean body weight-based contrast injection protocol in liver CT: optimization of contrast medium dose.La Radiologia medica · 2025Trial
- Renal protection CT protocol using low-dose and low-concentration iodine contrast medium in at-risk patients of HCC and with chronic kidney disease: a randomized controlled non-inferiority trial.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Trial
- Halved contrast medium dose in lower limb dual-energy computed tomography angiography-a randomized controlled trial.European radiology · 2023Trial
- A simple proteinuria-based risk score predicts contrast-associated acute kidney injury after percutaneous coronary intervention.Scientific reports · 2022Trial
- Is point of care renal function testing reliable screening pre-IV contrast administration?Emergency radiology · 2021Trial
- Effects of carnosic acid on renal injury-related parameters and iNOS immunoreactivity in an experimental model of contrast-associated acute kidney injury.Renal failure · 2026Article
- Carbon dioxide as a promising alternative to iodinated contrast media for lower extremity endovascular procedures (Review).Biomedical reports · 2026Review
- GLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study.Acta diabetologica · 2026Article
- Impact of contrast volume on medium- to long-term renal function in patients undergoing repeated percutaneous coronary interventions.International journal of cardiology. Heart & vasculature · 2026Article
- Diagnostic evaluation of renal masses in chronic kidney disease: a clinical and radiologic challenge.Abdominal radiology (New York) · 2026Review
- Non-occlusive mesenteric ischemia secondary to diabetic ketoacidosis in a patient receiving olanzapine: A case report.Radiology case reports · 2026Article
- Deep learning image reconstruction for 50-keV virtual monoenergetic dual-energy CT of the thyroid: a prospective "dual-low" dose study.European radiology · 2026Article
- Incremental value of hernia-sac CT attenuation beyond symptom duration for predicting bowel resection in incarcerated obturator hernia: a single-site retrospective cohort study.Hernia : the journal of hernias and abdominal wall surgery · 2026Article
- Article
- Photon-counting detector CT for CT pulmonary angiography: a systematic review and meta-analysis.European radiology · 2026Article
150 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration). Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, prophylaxis with intravenous normal saline is indicated for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.